The oncogenic fusion protein Pax3-FKHR has a greater post-translational stability relative to Pax3 during early myogenesis

Biochimica et Biophysica Acta - General Subjects

Volumn 1770, Issue 10, 2007, Pages 1450-1458

  Miller, Patrick J ^a   Hollenbach, Andrew D ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alveolar rhabdomyosarcoma; FKHR; Myogenesis; Pax3; Pax3 FKHR; Protein stability

Indexed keywords

HYBRID PROTEIN; MESSENGER RNA; TRANSCRIPTION FACTOR FKHR; TRANSCRIPTION FACTOR PAX3;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; HALF LIFE TIME; MOUSE; MUSCLE DEVELOPMENT; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN STABILITY;

ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; HUMANS; MICE; MICE, INBRED C57BL; MICROSCOPY, PHASE-CONTRAST; MUSCLE DEVELOPMENT; MYOBLASTS; ONCOGENE PROTEINS, FUSION; PAIRED BOX TRANSCRIPTION FACTORS; PROTEIN MODIFICATION, TRANSLATIONAL;

EID: 34548525530     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagen.2007.06.016     Document Type: Article

References (33)

1. Barr F.G. The role of chimeric paired box transcription factors in the pathogenesis of pediatric rhabdomyosarcoma. Cancer Res. 59 (1999) 1711s-1715s
2. Galili N., Davis R.J., Fredericks W.J., Mukhopadhyay S., Rauscher III F.J., Emanuel B.S., Rovera G., and Barr F.G. Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma. Nat. Genet. 5 (1993) 230-235
3. Shapiro D.N., Sublett J.E., Li B., Downing J.R., and Naeve C.W. Fusion of PAX3 to a member of the forkhead family of transcription factors in human alveolar rhabdomyosarcoma. Cancer Res. 53 (1993) 5108-5112
4. Hollenbach A.D., Sublett J.E., McPherson C.J., and Grosveld G. The Pax3-FKHR oncoprotein is unresponsive to the Pax3-associated repressor hDaxx. EMBO J. 18 (1999) 3702-3711
5. Hollenbach A.D., McPherson C.J., Lagutina I., and Grosveld G. The EF-hand calcium-binding protein calmyrin inhibits the transcriptional and DNA-binding activity of Pax3. Biochim. Biophys. Acta 1574 (2002) 321-328
6. Stuart E.T., Kioussi C., and Gruss P. Mammalian Pax genes. Annu. Rev. Genet. 28 (1994) 219-236
7. Bober E., Franz T., Arnold H.H., Gruss P., and Tremblay P. Pax-3 is required for the development of limb muscles: a possible role for the migration of dermomyotomal muscle progenitor cells. Development 120 (1994) 603-612
8. Goulding M., Lumsden A., and Paquette A.J. Regulation of Pax-3 expression in the dermomyotome and its role in muscle development. Development 120 (1994) 957-971
9. Tajbakhsh S., Rocancourt D., Cossu G., and Buckingham M. Redefining the genetic hierarchies controlling skeletal myogenesis: Pax-3 and Myf-5 act upstream of MyoD. Cell 89 (1997) 127-138
10. Maroto M., Reshef R., Munsterberg A.E., Koester S., Goulding M., and Lassar A.B. Ectopic Pax-3 activates MyoD and Myf-5 expression in embryonic mesoderm and neural tissue. Cell 89 (1997) 139-148
11. Anderson M.J., Viars C.S., Czekay S., Cavenee W.K., and Arden K.C. Cloning and characterization of three human forkhead genes that comprise an FKHR-like gene subfamily. Genomics 47 (1998) 187-199
12. Gajiwala K.S., and Burley S.K. Winged helix proteins. Curr. Opin. Struct. Biol. 10 (2000) 110-116
13. Modur V., Nagarajan R., Evers B.M., and Milbrandt J. FOXO proteins regulate tumor necrosis factor-related apoptosis inducing ligand expression. Implications for PTEN mutation in prostate cancer. J. Biol. Chem. 277 (2002) 47928-47937
14. Dijkers P.F., Medema R.H., Pals C., Banerji L., Thomas N.S., Lam E.W., Burgering B.M., Raaijmakers J.A., Lammers J.W., Koenderman L., and Coffer P.J. Forkhead transcription factor FKHR-L1 modulates cytokine-dependent transcriptional regulation of p27(KIP1). Mol. Cell. Biol. 20 (2000) 9138-9148
15. Medema R.H., Kops G.J., Bos J.L., and Burgering B.M. AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1. Nature 404 (2000) 782-787
16. Hall R.K., Yamasaki T., Kucera T., Waltner-Law M., O'Brien R., and Granner D.K. Regulation of phosphoenolpyruvate carboxykinase and insulin-like growth factor-binding protein-1 gene expression by insulin. The role of winged helix/forkhead proteins. J. Biol. Chem. 275 (2000) 30169-30175
17. Schmoll D., Walker K.S., Alessi D.R., Grempler R., Burchell A., Guo S., Walther R., and Unterman T.G. Regulation of glucose-6-phosphatase gene expression by protein kinase Balpha and the forkhead transcription factor FKHR. Evidence for insulin response unit-dependent and -independent effects of insulin on promoter activity. J. Biol. Chem. 275 (2000) 36324-36333
18. Daitoku H., Yamagata K., Matsuzaki H., Hatta M., and Fukamizu A. Regulation of PGC-1 promoter activity by protein kinase B and the forkhead transcription factor FKHR. Diabetes 52 (2003) 642-649
19. Nakae J., Kitamura T., Kitamura Y., Biggs III W.H., Arden K.C., and Accili D. The forkhead transcription factor Foxo1 regulates adipocyte differentiation. Dev. Cell 4 (2003) 119-129
20. Hu M.C., Lee D.F., Xia W., Golfman L.S., Ou-Yang F., Yang J.Y., Zou Y., Bao S., Hanada N., Saso H., Kobayashi R., and Hung M.C. IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a. Cell 117 (2004) 225-237
21. Nishiyama T., Kii I., and Kudo A. Inactivation of Rho/ROCK signaling is crucial for the nuclear accumulation of FKHR and myoblast fusion. J. Biol. Chem. 279 (2004) 47311-47319
22. Bois P.R., and Grosveld G.C. FKHR (FOXO1a) is required for myotube fusion of primary mouse myoblasts. EMBO J. 22 (2003) 1147-1157
23. Nakae J., Barr V., and Accili D. Differential regulation of gene expression by insulin and IGF-1 receptors correlates with phosphorylation of a single amino acid residue in the forkhead transcription factor FKHR. EMBO J. 19 (2000) 989-996
24. Matsuzaki H., Daitoku H., Hatta M., Tanaka K., and Fukamizu A. Insulin-induced phosphorylation of FKHR (Foxo1) targets to proteasomal degradation. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 11285-11290
25. Rando T.A., and Blau H.M. Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy. J. Cell Biol. 125 (1994) 1275-1287
26. Laker C., Meyer J., Schopen A., Friel J., Heberlein C., Ostertag W., and Stocking C. Host cis-mediated extinction of a retrovirus permissive for expression in embryonal stem cells during differentiation. J. Virol. 72 (1998) 339-348
27. Swift S., Lorens J., Achacoso P., and Nolan G.P. In: Coligan J.E., Kruisbeek A.M., Margulies D.H., Shevach E.M., and Strober W. (Eds). Current Protocols in Immunology (1999), John Wiley and Sons, Boston, MA 10.17
28. Lam P.Y., Sublett J.E., Hollenbach A.D., and Roussel M.F. The oncogenic potential of the Pax3-FKHR fusion protein requires the Pax3 homeodomain recognition helix but not the Pax3 paired-box DNA binding domain. Mol. Cell. Biol. 19 (1999) 594-601
29. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25 (2001) 402-408
30. Epstein J.A., Lam P., Jepeal L., Maas R.L., and Shapiro D.N. Pax3 inhibits myogenic differentiation of cultured myoblast cells. J. Biol. Chem. 270 (1995) 11719-11722
31. Ridgeway A.G., and Skerjanc I.S. Pax3 is essential for skeletal myogenesis and the expression of Six1 and Eya2. J. Biol. Chem. 276 (2001) 19033-19039
32. Epstein J.A., Shapiro D.N., Cheng J., Lam P.Y., and Maas R.L. Pax3 modulates expression of the c-Met receptor during limb muscle development. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 4213-4218
33. Rena G., Woods Y.L., Prescott A.R., Peggie M., Unterman T.G., Williams M.R., and Cohen P. Two novel phosphorylation sites on FKHR that are critical for its nuclear exclusion. EMBO J. 21 (2002) 2263-2271